摘要
目的 探讨硝普钠抢救老年心衰肺水肿的临床效果。方法 依不同治疗方式将2015年1月-2017年1月于本院诊治的老年心衰肺水肿患者50例分组为对照组与观察组,每组25例:对照组用常规药物治疗,观察组用常规药物+硝普钠治疗;详细记录2组患者各项实验数据,并将所获相关数据做对比分析,探讨硝普钠抢救老年心衰肺水肿的临床效果。结果 常规药物+硝普钠(观察组)治疗老年心衰肺水肿患者的临床效果优于单纯常规药物(对照组)治疗的临床效果,患者心衰、肺水肿血清相关蛋白指标显著改善,差异有统计学意义(P〈0.05);2组患者不良反应发生率比较,差异无统计学意义。结论 老年心衰肺水肿患者选择常规药物+硝普钠治疗效果显著,可充分改善各项临床症状,促使血清相关蛋白指标改善,不提高不良反应发生率,值得临床应用。
Objective To investigate the clinical efficacy of sodium nitroprusside on the treatment of pulmonary edema in elderly patients with heart failure. Methods 50 elderly cases with heart failure and pulmonary edema From January 2015 to January 2017 were divided into the control group and the observation group according to the different treatment methods. The control group were received conventional therapy, the observation group were given conventional drug combined with sodium nitroprusside. The experimental data was recorded and compared. To investigate the effect of sodium nitroprusside on the rescue of elderly heart failure and pulmonary edema. Results The clinical effect in the observation group is better than that in the control group. The protein related indexes about heart failure and pulmonary edema were significantly improved (P〈0.05). The difference of adverse reaction rate in the two groups has no statistically significat. Conclusion Conventional drug therapy combined with sodium nitroprusside were used on the treatment of elderly patients with heart failure, pulmonary edema, which can improve the clinical symptoms, related serum protein, without increasing the incidence of adverse reactions, it is worthy of clinical application.
出处
《中国生化药物杂志》
CAS
2017年第8期204-205,207,共3页
Chinese Journal of Biochemical Pharmaceutics
关键词
硝普钠
老年心衰
肺水肿
sodium nitroprusside
elderly heart failure
pulmonary edema